India signs deal with domestic vaccine maker Biological-E for 300 million doses

India signs deal with domestic vaccine maker Biological-E for 300 million doses The vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry said in a statement. https://ift.tt/eA8V8J